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Highlights  
 
- Sex cord-stromal tumors are the second most frequent category of testicular neoplasms.  
- They account for approximately 2-5% of testicular neoplasms in adults.  
- Both genetic and epigenetic factors account for their differences from ovarian SCSTs.  
- Undifferentiated gonadal tissue is the precursor of classical gonadoblastoma. 
- The most recent evidence strongly supports the existence of testicular MGC-SCST.  
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Summary Sex cord-stromal tumors (SCSTs) are the second most frequent category of testicular 
neoplasms, accounting for approximately 2-5% of cases. Both genetic and epigenetic factors 
account for the differences in frequency and histologic composition between testicular and 
ovarian SCSTs. For example, large cell calcifying Sertoli cell tumor and intratubular large cell 
hyalinizing Sertoli cell neoplasia occur in the testis but have not been described in the ovary. In 
this article, we discuss recently described diagnostic entities as well as inconsistencies in 
nomenclature used in the recent World Health Organization classifications of SCSTs in the testis 
and ovary. We also thoroughly review the topic of neoplasms composed of both germ cells and 
sex cord derivatives with an emphasis on controversial aspects. These include “dissecting 
gonadoblastoma” and testicular mixed germ cell-sex cord stromal tumor (MGC-SCST). The 
former is a recently described variant of gonadoblastoma that sometimes is an immediate 
precursor of germinoma in the dysgenetic gonads of patients with a disorder of sex development. 
Although the relationship of “dissecting gonadoblastoma” to the previously described 
undifferentiated gonadal tissue is complex and not entirely resolved, we believe that it is 
preferable to continue to use the term undifferentiated gonadal tissue for those cases that are not 
neoplastic and are considered to be the precursor of classical gonadoblastoma. Although the 
existence of testicular MGC-SCST has been challenged, the most recent evidence supports its 
existence; however, testicular MGC-SCST differs significantly from ovarian examples due to 
both genetic and epigenetic factors.  
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Introduction  
Sex cord-stromal tumors are the second most frequent category of testicular neoplasms, 
accounting for approximately 2-5% of cases in adults; however, they make up approximately 
25% of cases that occur in infants and children [1]. The incidence of sex cord-stromal tumors is 
lower in the testis than in the ovary, and the frequency of the different histological types varies 
substantially between the gonads [2, 3]. In the ovary, sex cord-stromal tumors account for 
approximately 6% of all primary ovarian neoplasms, and about half of these are in the fibroma-
thecoma group [4]. The sex cord-stromal tumor category consists of neoplasms that are composed 
of granulosa cells, fibroblasts, theca cells, Sertoli cells, or Leydig cells, either singly or in various 
combinations. 
Both genetic and epigenetic factors account for the significant differences in frequency 
and histologic composition between the different types of testicular and ovarian sex cord-stromal 
tumors. Thus, testicular sex cord-stromal tumors more frequently are composed of Sertoli or 
Leydig cells, whereas ovarian examples are composed more frequently of granulosa or theca 
cells. Paradoxically, however, Sertoli-Leydig cell tumor is rare in the testis, but accounts for 0.5% 
of all ovarian neoplasms [4]. Juvenile-type granulosa cell tumor is rare, accounting for < 0.5% of 
all testicular sex cord-stromal tumors; however, it is the most common testicular neoplasm in the 
first 6 months of life, and almost all cases occur in the first decade [1]. Although exceptions exist, 
tumors that are less differentiated or contain a sex cord component are more likely to show 
clinically aggressive behavior than those that are better differentiated or composed of only 
stromal elements. Precursor lesions for neoplasms in the sex cord-stromal tumor category have 
not been identified. 
 The latest World Health Organization (WHO) classification of tumors of the testis 
divides sex cord-stromal tumors into 2 categories: 1) pure sex cord or pure stromal tumors and 2) 
those that are composed of an admixture of sex cord and stromal elements [1]. Although the 
nomenclature would suggest that both adult and juvenile types of granulosa cell tumor are pure 
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neoplasms, in reality, each type sometimes contains a neoplastic theca cell component. We prefer 
to divide sex cord-stromal tumors into those showing predominantly testicular, ovarian, or 
indeterminate differentiation (Table). Although the nomenclature for testicular and ovarian sex 
cord-stromal tumors is similar for the most part, certain nuances exist. For example, the 
equivalent of testicular Sertoli cell tumor, not otherwise specified (NOS) is simply Sertoli cell 
tumor in the ovary because, thus far, no other types have been described. Leydig cell tumor and 
Sertoli cell tumor are the two most common sex cord-stromal tumors in adult men, although both 
neoplasms are, in fact, uncommon. Several histological types of ovarian sex cord-stromal tumors 
are characterized by somatic DICER1 hotspot mutations; however, such mutations were not 
detected in 15 testicular sex cord-stromal tumors [5]. 
Although the existence of the entity of mixed germ cell-sex cord stromal tumor (MGC-
SCST) of the testis has been challenged, the most recent evidence supports its existence; 
however, testicular neoplasms differ significantly in histological appearance and clinical behavior 
from ovarian examples due to both genetic and epigenetic factors [6, 7]. 
 
2. Sex cord-stromal tumors 
2.1. Sertoli cell tumor  
Sertoli cell tumor is rare in either gonad; however, testicular examples are about twice as 
frequent as those occurring in the ovary. Sertoli cell tumor can occur throughout life; but tends to 
be detected at an older age in men (mean 45 years) than in women (mean 30 years) [8, 9]. 
Clinical symptoms at presentation are usually nonspecific. Hormonal manifestations in patients, 
such as gynecomastia in males and isosexual pseudoprecocity in girls, are uncommon. Most 
Sertoli cell tumors are clinically benign; however, approximately 7% of testicular examples have 
metastases at presentation, whereas 11% (3 of 27 cases) of stage I ovarian tumors had pelvic-
abdominal recurrences within 9-36 months [8-10].  In the current WHO classification of testicular 
tumors, 3 histological variants of Sertoli cell tumor are recognized: Sertoli cell tumor, NOS, large 
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cell calcifying Sertoli cell tumor, and intratubular large cell hyalinizing Sertoli cell neoplasia [1]. 
Sertoli cell tumor, NOS occurs in either sex, whereas the 2 other subtypes have not been 
described in the ovary; thus, it is unnecessary to subtype ovarian Sertoli cell tumors [1, 11]. The 
histological appearance of Sertoli cell tumor, NOS of the testis and ovarian Sertoli cell tumor is 
strikingly similar; however, it is more difficult to establish a consistent morphological profile of 
ovarian Sertoli cell tumor because of the existence of more mimics. Immunohistochemistry is 
generally required for the diagnosis of ovarian Sertoli cell tumors, but it is of limited value in the 
distinction of ovarian Sertoli cell tumor from granulosa cell tumor, where morphological features 
remain the mainstay for diagnosis, particularly their patterns of cellular arrangement and their 
nuclear appearance. Recent observations indicate that molecular studies can greatly aid in this 
distinction [12-15].  
 
2.1.1.  Sertoli cell tumor, NOS  
Testicular Sertoli cell tumor is about twice as common as ovarian examples. Sertoli cell 
tumor, NOS demonstrates CTNNB1 mutations (the gene that encodes. β-catenin) in > 70% of 
neoplasms [1, 15]. About 40% of cases show gain in the X chromosome [16].  Sertoli cell tumor, 
NOS is usually well circumscribed and tan-white to yellow on macroscopic examination (Fig. 
1A). A lobular or nodular appearance at low magnification is distinctive in the better-
differentiated testicular and ovarian tumors. Histological examination typically shows a spectrum 
ranging from a well-differentiated tubular pattern to a diffuse solid proliferation. Rarely, alveolar 
or retiform patterns are seen. Lymphocytic infiltrate in testicular Sertoli cell tumor can 
occasionally lead to the mistaken diagnosis of seminoma [1]. Sertoli cell tumors usually have pale 
to eosinophilic cytoplasm but sometimes consists of lipid-rich cells, and the term lipid-rich 
Sertoli cell tumor is appropriate for those neoplasms composed entirely of lipid-rich cells [8, 9]. 
This variant, however, is observed mostly in the ovary and is associated with isosexual 
pseudoprecocity in girls.  
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Because testicular Sertoli cell tumor, NOS contains variable amounts of lipid; such 
neoplasms are no longer considered to be a separate entity (Fig. 1B) [17]. We recently 
encountered a case of lipid-rich Sertoli cell tumor, NOS with signet ring cells, an unusual finding 
(Fig. 1C). Two similar cases were reported as signet-ring stromal tumor of the testis [18, 19]. 
Although the World Health Organization referenced the latter cases, a category of signet-ring 
stromal tumor of the testis was not included in the latest classification of testicular tumors [1]. We 
believe that the 2 cases previously reported as signet-ring stromal cell tumor of the testis are more 
accurately classified as Sertoli cell tumor, NOS with a lipid-rich pattern and signet ring cells.  
Signet ring stromal cell tumor of the ovary differs significantly from the above-described 
testicular cases in that the former arises from spindle-shaped immature gonadal stromal cells and 
the vacuoles in the signet ring cells are hydropic rather than containing lipid [20, 21]. The term 
signet ring stromal cell tumor was chosen specifically to indicate origin of the neoplasm from 
ovarian stroma. Lipid-containing signet ring cells have previously been described in different 
types of ovarian sex cord-stromal tumors, including thecoma, and sclerosing stromal tumor [20, 
21]. 
In the testis, sclerosing Sertoli cell tumor, although originally classified separately, is 
now considered to be a variant of Sertoli cell tumor, NOS [1, 22]. Sclerosing Sertoli cell tumor is 
rare in the testis; it has not been reported as a separate entity in the ovary, but has been clearly 
illustrated [8, 9]. This testicular variant is typically small (80% < 2 cm) and well circumscribed. 
In most cases, it is characterized by solid or hollow tubules and/or long anastomosing cords in a 
hypocellular, densely sclerotic stroma. By definition, at least 50% of the neoplasm must consist 
of hyalinized stroma in order to establish the diagnosis of this variant [22]. Entrapped 
seminiferous tubules are frequently found in the neoplasm.  
Sclerosing Sertoli cell tumors < 2 cm in greatest dimension and lacking histological 
features associated with malignancy have a negligible risk of metastasis and are adequately 
managed by orchiectomy alone [22]. Only 2 malignant examples have been reported, one 
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displaying histological malignancy including cytologic atypia, frequent mitoses, vascular 
invasion, and invasive extratesticular growth, whereas another was clinically aggressive with 
bone metastasis and the subsequent death of the patient from disease [22, 23]. The occurrence of 
mutations of the CTNNB1 gene and nuclear displacement of β-catenin in both Sertoli cell tumor, 
NOS and its sclerosing variant support their close relationship [1, 15].  
Two or more of the following features: tumor size ≥ 5 cm, moderate to severe nuclear 
atypia, 5 or more mitoses per 10 high power fields, vascular invasion, and tumor necrosis are 
associated with adverse outcomes in testicular Sertoli cell tumor, NOS; however, only two of 
these features, moderate to severe nuclear atypia and 5 or more mitoses per 10 high power fields 
are useful indicators for a poor prognosis in corresponding ovarian neoplasms (Figs. 1D-F) [8, 9]. 
Sertoli cell tumor, NOS must be distinguished from macroscopic Sertoli cell nodule. The 
latter lesion either presents as a palpable testicular mass or is found incidentally on ultrasound 
and measures ≥ 0.5 cm [24, 25]. The largest macroscopic Sertoli cell nodule thus far published 
measured 1.7 cm in greatest dimension and contained numerous spermatogonia [26]. 
Histologically, macroscopic Sertoli cell nodule is composed of clusters of altered seminiferous 
tubules separated by testicular interstitial tissue. The altered tubules contain an admixture of 
immature Sertoli cells, variable numbers of spermatogonia, and globular deposits of basement 
membrane material at all levels of the involved tubules.  
 
2.1.2.  Large cell calcifying Sertoli cell tumor  
Large cell calcifying Sertoli cell tumor has only been reported in the testis. Cases 
typically occur in teenage boys and young adults, and about 60% are sporadic [1]. Approximately 
40% of cases are bilateral, and these are nearly always associated with the Carney complex. 
Germline mutations in the PRKAR1A gene on the long arm of chromosome 17 are found in a high 
proportion of Carney complex type 1-associated neoplasms and occasionally in apparently 
sporadic examples [27]. 
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Histologically, the tumor cells are arranged in solid tubules, nests, cords, or clusters. 
Calcification is the only distinctive macroscopic feature (Fig. 2A). As indicated by its name, the 
neoplastic cells are large and have abundant eosinophilic cytoplasm (Fig. 2B). About one-half of 
the neoplasms contain an intratubular component. The cytological features closely resemble those 
of Leydig cell tumor; however, the presence of calcification, the absence of Reinke crystals, the 
prominent tubular architecture, and larger cell size are sufficient for the differential diagnosis 
[28]. Clinically aggressive behavior is uncommon. Malignant large cell calcifying Sertoli cell 
tumors have 2 or more of the following features: extratesticular spread, tumor size ≥ 4 cm, 
mitoses  > 3 per 10 high power fields, significant nuclear atypia, necrosis, lymphatic or blood 
vascular invasion [29, 30].  
 
2.1.3. Intratubular large cell hyalinizing Sertoli cell neoplasia  
Intratubular large cell hyalinizing Sertoli cell neoplasia is a distinct variant of Sertoli cell 
tumor that occurs almost exclusively in boys with the Peutz-Jeghers syndrome [31]. Patients 
usually present with gynecomastia. Germline mutation in the STK11 gene is the causation of the 
Peutz-Jeghers syndrome and is also central to the development of large cell hyalinizing Sertoli 
cell neoplasia [1]. These intratubular lesions are small, bilateral, and multifocal. They have a 
patchy distribution and are characterized by expanded seminiferous tubules that are filled with 
large eosinophilic or vacuolated Sertoli cells and globular deposits of basement membrane 
material that extend from the thickened peritubular basement membrane (Figs. 2C and D). 
Calcification occurs occasionally in the basement membrane material. Because of its typical 
intratubular location, metastases are unlikely to occur. Uncommonly, these neoplasms invade the 
testicular interstitium and, thereby, histologically resemble large cell calcifying Sertoli cell tumor.  
The corresponding tumor in girls with the Peutz-Jeghers syndrome is known as sex cord 
tumor with annular tubules [10]. The histological differences between testicular intratubular large 
cell hyalinizing Sertoli cell neoplasia and ovarian sex cord tumor with annular tubules are likely 
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related to both genetic and epigenetic factors. 
 
2.2 Leydig cell tumor  
Leydig cell tumors comprise 1-3% of testicular neoplasms and can occur at any age, but 
are more common in prepubertal boys and in men aged 30 to 60 years. These neoplasms can 
produce androgens or estrogens, and about 30% of patients present with gynecomastia. Leydig 
cell tumors are always benign in boys, whereas 10% of the cases in adults are malignant [32, 33].  
           On the sectioned surface, these neoplasms are red-brown to yellow. Histologically, 
seminiferous tubules are often entrapped at the periphery of the tumor (Fig. 3A). Most neoplasms 
have a diffuse pattern and are composed of polygonal cells with abundant eosinophilic cytoplasm 
and uniform round nuclei with small nucleoli (Fig. 3B). Reinke crystals are identified in about 
30% of cases, and lipofuscin pigment is observed in about 15% [1]. Malignant Leydig cell tumors 
are typically large (≥ 4 cm), have infiltrating margins, invade lymphatics or blood vessels, have a 
high mitotic rate (≥ 3 per 10 high power fields, and exhibit nuclear atypia (Figs. 3C and D) [30]. 
In a series of 40 cases of testicular Leydig cell tumor, all 5 clinically malignant cases had 4 or 
more of the above histological features [32]. 
 
2.3. Sertoli-Leydig cell tumor 
Sertoli-Leydig cell tumors are exceptionally rare in the testis, whereas they account for 
0.5% of ovarian neoplasms [10]. Six previously reported putative cases that contained both 
tubular and Leydig cell components were recently reviewed, however, the diagnosis could not be 
definitely confirmed because of the lack of immunocytochemical stains and high quality images 
[30]. At least 1 documented well-differentiated Sertoli-Leydig cell tumor involving the testis has 
been reported [34]. Furthermore, a moderately differentiated neoplasm was recently illustrated in 
the recent WHO Classification of Tumours of the Urinary System and Male Genital Organs (see 
Fig. 4.63, p.228) [1]. 
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Because of its rarity in the testis, our knowledge of this neoplasm comes almost 
exclusively from the ovarian entity. Sertoli-Leydig cell tumors can be divided into three main 
subtypes based on their degree of differentiation: well, moderately, or poorly differentiated. The 
moderately and poorly differentiated neoplasms sometimes contain retiform or heterologous 
components or both. Well-differentiated Sertoli-Leydig cell tumors are characterized by a lobular 
structure composed of hollow or solid tubules and a mature fibrous stromal component containing 
a substantial number of Leydig cells. Moderately differentiated neoplasms show a conspicuously 
nodular growth pattern. Both Sertoli cells and Leydig cells are mixed in the nodules and may 
display varying degrees of architectural and cytological immaturity. Leydig cells are much less 
common than in the well-differentiated neoplasms. Poorly differentiated Sertoli-Leydig cell 
tumors have a diffuse pattern resembling fibrosarcoma. By definition, they should have at least 
small foci of diagnostic elements that are composed of Sertoli cells and Leydig cells. 
Heterologous elements occur in approximately 20% of Sertoli-Leydig cell tumors, but not in the 
well-differentiated type. They may manifest as glands or cysts lined by gastrointestinal 
epithelium, and/or heterologous mesenchymal elements such as fetal-type cartilage or embryonal 
rhabdomyosarcoma. The epithelial components sometimes contain goblet cells and argentaffin 
cells that can occasionally form a goblet cell or an insular carcinoid. Exceptionally, hepatoid or 
renal tissue may be encountered in Sertoli-Leydig cell tumors. About 15% of moderately or 
poorly differentiated Sertoli-Leydig cell tumors contain retiform elements. The retiform pattern 
usually makes up only a portion of the neoplasm, but occasionally the entire tumor is retiform. 
Retiform areas typically show a network of irregularly branching, elongated slit-like tubules and 
cysts. Papillae or polypoid structures can project into these structures. 
 
2.4. Granulosa cell tumor  
Granulosa cell tumors are currently classified into adult and juvenile types based on their 
histological appearance; they are much more common in the ovary than in the testis. Granulosa 
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cell tumors of either adult or juvenile type are almost invariably unilateral. The adult type 
accounts for 95% of ovarian granulosa cell tumors, whereas, in the testis, the 2 types have a more 
balanced distribution. In the testis, juvenile-type granulosa tumor is the most common neoplasm 
in the first 6 months of life.  
Testicular granulosa cell tumor is rare, although corresponding ovarian neoplasms are the 
most common malignant sex cord-stromal tumor, accounting for approximately 12% of cases [4, 
30]. Although the term granulosa cell tumor connotes that it is composed purely or at least 
predominantly of granulosa cells, in reality, both the juvenile and adult types occasionally have a 
neoplastic theca cell component.  
 
2.4.1. Adult-type granulosa cell tumor  
Adult-type granulosa cell tumor is rare, accounting for < 0.5% of testicular sex cord-
stromal tumors [1]. The neoplasms are almost invariably unilateral. Testicular and ovarian adult-
type granulosa cell tumors not only have a similar FOXL2 codon 134.  
 Macroscopically, adult-type granulosa cell tumor typically appears as a solid, cystic, or 
solid and cystic mass with a yellow-tan hue on the sectioned surface. Histologically, the diffuse 
and microfollicular patterns, the latter with Call-Exner bodies, are the most common in testicular 
examples [35]. Granulosa cell tumors occasionally show a mixed cell population of granulosa 
cells, theca cells and fibroblasts. Exceptionally, the granulosa cells are luteinized. The neoplastic 
granulosa cells typically have pale nuclei that frequently show a longitudinal groove. Bizarre 
nuclei have not, thus far, been reported in testicular examples. Features that can be associated 
with aggressive behavior include size > 4 cm, infiltrative borders, and lymphatic or blood 
vascular invasion [35].  
 
2.4.2 Juvenile-type granulosa cell tumor  
Juvenile-type granulosa cell tumor is rare, accounting for < 0.5% of all testicular SCSTs; 
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however, it is the most common testicular neoplasm in the first 6 months of life, and almost all 
cases occur in the first decade [1]. All neoplasms reported to date have been benign. 
On macroscopic examination, these tumors are well circumscribed and vary from solid to 
cystic. The sectioned surface varies from yellow to tan-white. Histological examination shows a 
solid pattern with focal follicular formation or a uniformly follicular pattern (Fig. 4A). The 
follicles contain basophilic or eosinophilic fluid that stains with mucicarmine and are lined by an 
inner layer of granulosa cells sometimes surrounded by an outer layer of neoplastic theca cells 
(Figs. 4B). Occasionally, the granulosa cells appear to be luteinized. The neoplastic granulosa 
cells are distinguished from those of the adult type in that they have round dense nuclei that lack 
nuclear grooves. Mitotic figures are more frequent than in the adult type. Classical Call-Exner 
bodies and pale or grooved nuclei are not encountered. The primary differential diagnosis is 
juvenile-type yolk sac tumor. Juvenile-type granulosa cell tumor is almost always positive for 
steroidogenic factor 1, whereas SALL4, glypican-3, and alpha-fetoprotein are negative in the 
neoplastic granulosa cells. 
 
2.5 Tumors in the fibroma group  
Although the fibroma-thecoma group accounts for at least 4% of ovarian tumors, < 30 
cases have been reported in the testis [36-38]. In the interest of scientific parsimony, we prefer the 
terminology recommended in the WHO classification of ovarian tumors [11]. To the best of our 
knowledge, no cases of thecoma or sclerosing stromal tumor have been reported in the testis; 
therefore, the term fibrothecoma used in the latest WHO classification of testicular tumors does 
not seem appropriate [1]. Thus, we diagnose testicular neoplasms in this group simply as fibroma 
or cellular fibroma. None of the tumors reported thus far have been clinically aggressive [36, 37].  
These neoplasms occur mostly in middle aged or elderly men and are almost invariably 
unilateral. On the sectioned surface, they are well circumscribed and white. Entrapped 
seminiferous tubules are occasionally encountered at the periphery of the neoplasm (Fig. 5A). 
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Histological examination of typical and cellular fibroma shows oval to spindle-shaped cells 
arranged in a fascicular or storiform pattern sometimes containing fibrous bands or hyaline 
plaques [36] (Fig. 5B). The nuclei of cellular fibromas are more densely packed and mitotically 
active, containing as many as 5 mitotic figures per 10 high power fields, and hyaline plaques also 
can occur [37] (Figs. 5C and D).  
 
2.6. Myoid gonadal stromal tumor   
Myoid gonadal stromal tumor is classified as an emerging entity in the latest WHO 
classification of testicular tumors despite the fact that it was first reported as such in 1991; to 
date, < 10 cases have been reported [1]. Although this tumor can occur at almost any age, the 
typical presentation is a testicular mass in a young or middle-aged man. All cases reported to date 
have had an uneventful follow up. Thus far, no corresponding neoplasm has been described in the 
ovary. 
Myoid gonadal stromal tumor is composed of densely packed spindle-shaped cells 
arranged in short fascicles that have features of both smooth muscle and gonadal stroma [39]. The 
existence of such a neoplasm is not altogether unexpected since ovarian stroma and granulosa cell 
tumor, thecoma, and fibroma are all known to show smooth muscle differentiation to varying 
degrees, however for the same reason we consider the concept to be problematic [40]. 
In 1977, Evans and Glick [41] reported the first case as an unusual gonadal stromal tumor 
that occurred in a 4-year old boy.  In, 1984, Greco et al. [42] reported 2 cases as testicular stroma 
tumor with myofilaments. In 1991, Weidner [43] introduced the term myoid gonadal stromal 
tumor, and, in 2012, Du et al. [44] of the same group compared their findings in another case to 
the normal adjacent peritubular myoid cells and observed similar immunoreactivity. They 
believed that myoid gonadal stromal tumor shows peritubular myoid cell differentiation.  
In 1996, Nistal et al. [45] reported a case as fusocellular gonadal stroma tumor of the 
testis with epithelial and myoid differentiation and suggested origin from peritubular myoid cells. 
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The challenge of establishing a diagnosis of myoid gonadal stromal tumor was exemplified by 
Jones et al. [36] who interpreted the aforementioned  case as a fibroma of gonadal stromal origin. 
In 1997, Renshaw et al. [46] reported 4 cases of unclassified sex cord-stromal tumors of the testis 
with a predominance of spindle cells, although their case 4 was composed entirely of elongated 
spindle cells reminiscent of smooth muscle differentiation on hematoxylin and eosin staining. In 
areas of all of their cases, however, reticulin enveloped variably sized aggregates of tumor cells 
rather than individual cells confirming the identification of a sex cord component. 
In 2014, Kao and Ulbright [39] reported 3 cases of myoid gonadal stromal tumor and 
reviewed the prior literature; they concluded that the neoplasm originates from intertubular 
primitive mesenchymal cells that undergo myogenic differentiation rather than from peritubular 
myoid cells. They specifically excluded predominantly spindle cell tumors with sex cord 
differentiation appreciable on hematoxylin and eosin or reticulin stains from the myoid gonadal 
stromal category.  
We believe that further study of this rare and enigmatic tumor is necessary to verify its 
existence as a distinct entity, to establish its histogenesis, and to develop reliable histological and 
immunocytochemical criteria that can distinguish it from other pure testicular stromal neoplasms, 
particularly testicular fibroma.  
 
2.7. Unclassified and mixed sex cord-stromal tumors  
Unclassified and mixed sex cord-stromal tumors are rare in the testis. They are best 
considered to be in the indeterminate category because they lack predominant differentiation in 
either the testicular or ovarian direction. Although they can occur at any age, they typically 
present in middle-aged or elderly men [1]. Approximately one-third of cases, however, present in 
children [30]. The usual presentation is a painless testicular mass.  
The unclassified type consists of sex cord elements having features intermediate between 
Sertoli and granulosa cells as well as stromal elements (Figs. 6A and B). The mixed type consists 
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of various combinations of sex cord elements that show differentiation either toward Sertoli cells 
or granulosa cells from area to area. Reticulin stains can be helpful in the diagnosis of 
unclassified or mixed sex cord stromal tumor since the sex cord elements have inconspicuous 
reticulin fibers, whereas reticulin surrounds individual stromal cells. Occasional neoplasms in 
either category are clinically malignant, and these display similar histological features to those 
used to distinguish malignant Sertoli cell or Leydig cell tumors from benign examples [1]. To the 
best of our knowledge, no case corresponding to gynandroblastoma has been described in the 
testis, although such neoplasms occur rarely in the ovary.  
 
3. Tumors composed of both germ cells and sex cord-stromal derivatives  
In the latest classification of testicular neoplasms, the WHO includes a category of 
tumors containing both germ cells and sex cord-stromal elements immediately after that of sex 
cord-stromal tumors [1]. We include both gonadoblastoma and MGC-SCST in this category, 
although the latter was excluded from the fourth edition of the WHO classification of tumors of 
the testis. Because of differing viewpoints in the literature regarding the existence of testicular 
MGC-SCST, the Editors deemed that there was insufficient evidence at the time of publication to 
include the category of MGC-SCST in the WHO classification [47]. However, we believe that the 
findings in recent articles strongly support the existence of testicular MGC-SCST as a distinct 
entity [7, 48, 49]. 
 
3.1. Gonadoblastoma 
3.1.1. Clinical findings  
In 1953, Scully [50] first described classical gonadoblastoma. Later, in a seminal article, 
he reported a series of 74 cases [51]. Gonadoblastoma occurs almost entirely in the dysgenetic 
gonads of individuals who have a disorder of sex development associated with a Y-chromosome 
or part thereof [52]. Approximately 20% of gonadoblastomas occur in phenotypic males, who are 
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most often < 20 years of age [30]. The clinical presentation in the latter cases commonly includes 
cryptorchidism, hypospadias, and gynecomastia [51]. Gonadoblastoma occurs predominantly in 
phenotypic females with gonadal dysgenesis and an abnormal karyotype, but occurs exceptionally 
in apparently normal females with a 46 XX karyotype [11]. The most common predisposing 
conditions are 45, X/46, XY partial gonadal dysgenesis, 46, XY complete gonadal dysgenesis, 
and 46, XY disorder of sex development, formerly known as male pseudohermaphroditism [52, 
53]. In a patient with a disorder of sex development, at least 1 gonad is developmentally 
abnormal; however, histological confirmation would not be possible if the gonad has been 
completely replaced by neoplasm.  
  The gonadoblastoma susceptibility region on the short arm of the Y chromosome (GBY) 
is the only oncogenic region on the human Y chromosome and predisposes the dysgenetic gonads 
of XY individuals to develop an in situ tumor; TSPY1 is the putative gene [52, 54, 55]. If a gonad 
in a patient who has a disorder of sex development contains germ cells with delayed maturation 
and also harbors the TSPY1 gene, the cells may undergo transformation to gonadoblastoma [56]. 
The germ cells that have delayed maturation express OCT4 [57].  
 
3.1.2. Histology and immunocytochemistry 
 Classical gonadoblastoma is a noninvasive neoplasm composed of cellular nests or 
islands surrounded by gonadal stroma of variable cellularity. About 40% of gonadoblastomas are 
bilateral [1]. Histologically, the nests are composed of germ cells intimately admixed with 
immature sex cord derivatives, and the latter often surround hyaline basement membrane deposits 
(Fig. 7A). In some instances, stromal steroid cells are noted. The germ cells of individual cases of 
gonadoblastoma are heterogeneous, being composed of both mature and immature germ cells 
[58]. The mature germ cells resemble spermatogonia and express TSPY1, whereas the immature 
germ cells resemble those of germinoma, express OCT4, and are considered to be the precursor 
of the malignant germ cell neoplasms associated with gonadoblastoma [59].  
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Frequently, classical gonadoblastoma shows involutional changes including deposits of 
basement membrane material, hyalinization, and calcification (Figure 7B). Rarely, the 
involutional changes are extensive resulting in a calcified mass without any viable neoplastic 
cells. We refer to such cases as involuted gonadoblastoma; although such cases were originally 
described as “burnt out” gonadoblastoma [51].  
 
3.1.3. Undifferentiated gonadal tissue  
 Undifferentiated gonadal tissue is defined as gonadal tissue containing germ cells not 
enclosed in seminiferous tubules or follicles that either resides without apparent organization in a 
background of cellular gonadal stroma or is organized together with sex cord elements into cord-
like structures [57, 60]. Undifferentiated gonadal tissue occurs exclusively within dysgenetic 
gonads and has been proposed as the precursor of classical gonadoblastoma [57, 61]. In 67% of 
cases of classical gonadoblastoma that contained adjacent gonad, undifferentiated gonadal tissue 
was identified [57]. The germ cells in both undifferentiated gonadal tissue and classical 
gonadoblastoma are heterogeneous; they can express TSPY1, OCT4, or can co-express the two 
[57].   
 
3.1.4. Relationship of classical gonadoblastoma to malignant germ cell tumors  
Classical gonadoblastoma represents the precursor of germinoma and other invasive 
malignant germ cell neoplasms in patients who have a disorder of sex development [62]. Thus, 
classical gonadoblastoma can be interpreted as an in situ germ cell neoplasm that occurs in 
dysgenetic gonads that are predisposed to malignant transformation, most commonly to 
germinoma [59]. In 60% of cases of classical gonadoblastoma, an associated malignant germ cell 
tumor is encountered, and in 80% of the latter cases, the neoplasm is germinoma (Figs. 7B) [4]. 
However, patients with classical gonadoblastoma sometimes develop a more aggressive germ cell 
tumor, including yolk sac tumor, embryonal carcinoma, or immature teratoma [63]. SALL4 is 
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diffusely expressed in the germ cells of both gonadoblastoma and germinoma (Figs. 7C). 
Ulbright and Young [64] recently reviewed gonadoblastoma and other selected aspects of gonadal 
pathology in patients that have a disorder of sex development. 
 
3.1.5. “Dissecting gonadoblastoma”  
In a recent investigation of 50 cases of classical gonadoblastoma, Kao et al. [65] 
described a morphologic variant in 38 cases that they referred to as “dissecting gonadoblastoma.” 
They considered “dissecting gonadoblastoma” to be a variant of classical gonadoblastoma that 
showed similar immunohistochemical findings. In their model, classical gonadoblastoma was 
believed to be the intermediate lesion between the cord-like/anastomosing phase and the 
solid/expansile form of “dissecting gonadoblastoma.”  
The prime importance of this variant is that several growth patterns in which the number 
of sex cord cells appear reduced can be misinterpreted as germinoma [65]. They described 3 
patterns: solid expansile, anastomosing, and cord-like. The cord-like pattern can be confused with 
a similar pattern that has been described in germinoma resulting in more aggressive clinical 
treatment than necessary (Fig. 7D) [30]. The application of inhibin or steroidogenic factor 1 
immunohistochemical stains facilitates the identification of residual sex cord elements and is 
often useful in distinguishing “dissecting gonadoblastoma” from germinoma [65].  
 
3.1.6. Distinction of undifferentiated gonadal tissue from “dissecting gonadoblastoma” 
At the present time, the relationship of  “dissecting gonadoblastoma” to undifferentiated 
gonadal tissue is controversial and unresolved. We believe that it is preferable to continue to use 
the term undifferentiated gonadal tissue for those cases that are considered to be the precursor of 
gonadoblastoma, as was recommended in the latest WHO classification of testicular tumors (p. 
237), and to limit the use of “dissecting gonadoblastoma” to those cases with a solid expansile, 
cord-like, or other patterns that can be confused with germinoma [1]. We consider clonal 
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expansion of germ cells in “dissecting gonadoblastoma” to be the likely immediate precursor of 
some germinomas, and, therefore, such expansion should be a requirement for the diagnosis of 
“dissecting gonadoblastoma.”  
Undifferentiated gonadal tissue has been described morphologically as germ cells with 
delayed development within immature sex cords or isolated in the interstitium [57, 60]. 
Undifferentiated gonadal tissue is by definition a non-neoplastic process and, therefore, should be 
distinguished from “dissecting gonadoblastoma,” as the latter is a neoplastic process that is 
sometimes the precursor of germinoma. Although a cord-like pattern is a feature of some 
examples of undifferentiated gonadal tissue and some “dissecting gonadoblastomas,” the 
distinction can be made histologically by careful examination of other features of “dissecting 
gonadoblastoma” including an expansive growth pattern and proliferation of transformed germ 
cells.  
 
3.2. Mixed germ cell-sex cord stromal tumor  
In contrast to gonadoblastoma, MGC-SCST occurs in phenotypically normal individuals 
without sex chromosomal abnormalities, and both gonads are developmentally normal [53]. 
MGC-SCST shows significant differences in frequency, histological appearance, and biological 
behavior depending on whether the neoplasm originates in the testis or the ovary. Both genetic 
and epigenetic factors likely account for these dissimilarities.  
In 1972, Talerman [66, 67] described separately the first 2 cases of ovarian MGC-SCST. 
Nearly 10 years later, Bolen [68] reported the first testicular case. Testicular MGC-SCST is often 
composed of an intimate mixture of germ cells and sex-cord derivatives; however, the germ cells 
are variable in quantity and distribution, occasionally making the diagnosis challenging.  
Only 10% of cases in girls and women are associated with malignant germ cell tumors, 
far less than the incidence in classical gonadoblastoma (50-60%). Intriguingly, testicular cases 
have not been found to be associated with clinically malignant germ cell tumors to date [7, 69]. 
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However, a case of MGC-SCST in a 7-year-old boy with precocious pseudopuberty contained 
some histologically and immunohistochemically malignant germ cells resembling those of 
seminoma as well as immature sex cord elements [70]. The seminoma-like germ cells likely 
occurred as a result of an additional mutation in the germ cells of the neoplasm.  
Macroscopically, testicular MGC-SCSTs are variable in size, well delimited, and solid 
gray-white on the sectioned surface (Fig. 8A). Testicular MGC-SCSTs often contain entrapped 
seminiferous tubules in which the germ cells are confined to the basal compartment (Fig. 8B). 
Occasionally, an intratubular component is identified (Fig. 8C). The intratubular component 
shows clonal expansion of germ cells and has been shown to be the precursor of invasive MGC-
SCST in a few cases [7]. In a majority of cases of invasive MGC-SCST, the germ cells form an 
integral part of the neoplasm (Fig. 8D). Histologically, MGC-SCST lacks the nest-like pattern 
and the involutional changes of basement membrane deposition, hyalinization, and calcification 
that are often observed in classical gonadoblastoma.  
Although the existence of the entity of MGC-SCST of the testis has been challenged, the 
most recent evidence strongly supports its occurrence; however, testicular tumors differ 
significantly from ovarian examples both in their biological behavior and their histological 
appearance [6, 7, 48, 49].  
  
4.0. Conclusion  
For the most part, the testis and ovary share similar categories of sex cord-stromal 
tumors; however, for specific categories, the neoplasms have different frequencies, subtypes, and 
clinicopathological features. Our knowledge of sex cord-stromal tumors has advanced in recent 
years incorporating the description of some novel morphological variants, the discovery of the 
FOXL2 mutation in granulosa cell tumors and some other sex cord-stromal tumors, and DICER1 
somatic mutations in several types of ovarian sex cord-stromal tumors, but not so far in similar 
testicular neoplasms.  
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 Careful morphologic observations together with detailed clinical information remain 
fundamental for the diagnosis of gonadal sex cord-stromal tumors and those that have an 
additional germ cell component. Although our knowledge of the pathobiology and molecular 
genetics of these neoplasms will increase in the future, incorporation of classical histopathology 
and immunocytochemistry will result in optimal patient care. Thus, we believe that diagnostic 
pathologists will play an essential role in this process for the foreseeable future 
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Figure Legends  
 
Fig. 1   Sertoli cell tumor, not otherwise specified (NOS). A, The sectioned surface of the testis 
contains a small well-circumscribed ovoid white nodule near the tunica albuginea. B, The 
neoplasm consists of irregular solid tubules within a fibrous stroma. The tumor cells have small, 
centrally located nuclei and finely vacuolated, lipid-rich cytoplasm (hematoxylin and eosin 
[H&E], original magnification, x400). C, Diffusely arranged tumor cells have pale cytoplasm 
with cytoplasmic vacuolization due to lipid and occasional signet ring cell formation (arrows) 
(H&E, x200). Inset, Signet ring cell in the central portion of the field contains a large cytoplasmic 
vacuole that compresses a bland eccentrically located, crescent-shaped nucleus resembling a 
signet ring. D, Malignant Sertoli cell tumor. Nodules of tumor infiltrate the rete testis (H&E, 
x40). E, The malignant Sertoli cell tumor has a diffuse growth pattern to the left with extensive 
tumor necrosis to the right (H&E, x100). F, The malignant Sertoli cell tumor shows moderate 
nuclear pleomorphism with enlarged nuclei and a distinct nucleolus. Note an abnormal mitotic 
figure in the upper central portion of the field (arrow) (H&E, x400).  
 
Fig. 2   Other types of Sertoli cell tumor.  A, Large cell calcifying Sertoli cell tumor consists of 
irregular cords of neoplastic cells, some of which contain mulberry calcifications seen centrally 
and in the lower left (H&E, x400). B, The tumor cells have abundant eosinophilic cytoplasm 
(H&E, x600). C, Intratubular large cell hyalinizing Sertoli cell neoplasia is composed of 
expanded seminiferous tubules containing hyaline basement membrane material in a cribriform 
arrangement. The uninvolved testicular tubules seen above and to the right are atrophic and 
surrounded by thickened basement membranes (H&E, x100). D, The intratubular component 
consists of enlarged tubules lined by Sertoli cells surrounding hyaline nodules composed of 
basement membrane material. A cluster of non-neoplastic Leydig cells is present in the right 
lower portion of the field (H&E, x200). 
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Fig. 3   Leydig cell tumor. A, Histologically benign neoplasm is composed of polygonal cells 
with abundant eosinophilic cytoplasm surrounding an entrapped seminiferous tubule in the left 
upper part of the field (H&E, x200).  B, The neoplastic cells have uniform bland nuclei with a 
small nucleolus and abundant eosinophilic cytoplasm (H&E, x600). C, Malignant Leydig cell 
tumor is composed of irregular clusters of neoplastic cells with enlarged pleomorphic nuclei and 
eosinophilic cytoplasm supported by a delicate vasculature (H&E, x400). (D) Neoplasm extends 
into a thin-walled vascular space containing erythrocytes (arrow), (H&E, x100).  
 
Fig. 4  Juvenile-type granulosa cell tumor. A, Neoplasm forms confluent cystic follicles 
containing basophilic mucin (H&E, x100). B, The follicular structures are lined by layers of 
granulosa cells with small closely packed nuclei surrounded by neoplastic theca cells that have 
oval to elongated nuclei and indistinct cytoplasm. The granulosa cell nuclei are uniform and 
dense, lacking nuclear grooves (H&E, x400).  
 
Fig. 5  Tumors in the fibroma group. A, Fibroma is composed of intersecting fascicles of spindle-
shaped cells with bland nuclei.  Residual testis with seminiferous tubules is seen to the left (H&E, 
x100). B, Short fascicles of spindle-shaped neoplastic cells are observed (H&E, x200). C, 
Cellular fibroma is composed of tumor cells with high nuclear to cytoplasmic ratios surrounding 
nodular areas of fibrosis and hyalinization (H&E, x400). D, The cell nuclei are small, round to 
oval, densely packed and the cytoplasm is indistinct. Note the mitotic figure in the right upper 
part of the field (arrow),  (H&E, x400).  
 
Fig. 6   Unclassified sex cord-stromal tumor A, Neoplastic cells are diffusely distributed and 
closely packed with formation of vague cords (H&E, x100). (B) The neoplastic cells resemble 
immature sex cord cells and have round to oval nuclei with small or indiscernible nucleoli and 
scant indistinct cytoplasm (H&E, x400). 
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Fig. 7  Gonadoblastoma and related neoplasms. A, Classical gonadoblastoma is composed of cellular 
islands separated by hyaline basement membrane material. The islands are made up of germ cells and sex 
cord elements. Two types of germ cells are identified. Some germ cells have uniform bland nuclei with 
small nucleoli and abundant cytoplasm resembling spermatogonia, whereas others have larger nuclei with a 
prominent nucleolus resembling those of germinoma. The sex cord elements sometimes surround hyaline 
bodies composed of basement membrane material  (H&E, x600). B, A thin fibrous band separates classical 
gonadoblastoma containing a mulberry calcification (arrow) in the lower portion of the field from 
germinoma composed of primitive malignant germ cells with enlarged nuclei and clear cytoplasm in the 
upper third (H&E, x400). (C) An island of classical gonadoblastoma in the center of the field is surrounded 
by germinoma. The germ cell nuclei in both neoplasms express SALL4. The nuclei in the nest of 
gonadoblastoma vary in size. The smaller nuclei resemble spermatogonia and the larger nuclei are those of 
germinoma (SALL4, x200). D, “Dissecting gonadoblastoma” composed of small cords of cells in a fibrous 
stroma in the lower and right portion of the field is separated from germinoma in the upper left by a thick 
wavy fibrous band (H&E, x100). Inset. The cords of “dissecting gonadoblastoma” are composed 
predominantly of germ cells, but a few residual sex cord derivatives can be identified mostly at their 
periphery. 
Fig. 8   Mixed germ cell-sex cord-stromal tumor (MGC-SCST) of the testis. A, The sectioned surface of the 
testis shows a circumscribed gray-white tumor nodule in the central portion. B, Spermatogonia in the basal 
compartment of entrapped seminiferous tubules express SALL4; however, in the invasive component of the 
neoplasm, germ cells were variably distributed, and none were identified in this field (SALL4, x100).   C, 
Intratubular component of MGC-SCST consists of an expanded tripartite tubule composed of numerous 
transformed spermatogonia with variably sized nuclei and immature sex cord cells surrounded by 
neoplastic immature sex cord cells (H&E, x600). D, Invasive MGC-SCST is composed of an admixture of 
neoplastic immature sex cord cells and transformed germ cells resembling spermatogonia, but with variably 
sized nuclei that form an integral part of the tumor and (H&E, x600).  
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Table 1. Classification of testicular sex cord-stromal tumors according to histologic 
differentiation  
Differentiation Type of tumor Subtype 
Testicular Sertoli cell tumor Not otherwise specified (NOS)  
  
  
  
  
Malignant 
 Large cell calcifying Sertoli cell tumor  
  
  
Intratubular large cell Sertoli cell neoplasia 
 
  Leydig cell tumor Not otherwise specified (NOS) 
  
  
  
Malignant 
  Sertoli-Leydig cell tumor Well differentiated 
  
  
  
  
Moderately differentiated 
  
  
  
  
Poorly differentiated 
Ovarian Granulosa cell tumor  Adult type  
  
  
  Juvenile type 
  Fibroma Not otherwise specified (NOS) 
  Cellular 
Indeterminate Myoid gonadal stromal tumor*  
 Sex cord-stromal tumor Unclassified type 
    Mixed type 
  
Malignant 
 
* Emerging entity  
